Last $411.99 USD
Change Today -3.14 / -0.76%
Volume 539.9K
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

intuitive surgical inc (ISRG) Snapshot

Open
$415.00
Previous Close
$415.13
Day High
$417.53
Day Low
$410.02
52 Week High
04/3/14 - $541.23
52 Week Low
12/17/13 - $351.14
Market Cap
15.8B
Average Volume 10 Days
974.3K
EPS TTM
$16.73
Shares Outstanding
38.3M
EX-Date
--
P/E TM
24.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for INTUITIVE SURGICAL INC (ISRG)

intuitive surgical inc (ISRG) Details

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci surgical system translates a surgeon’s natural hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci surgical system comprise a surgeon’s console, a patient-side cart, a 3-D vision system, da Vinci skills simulator, and Firefly fluorescence imaging product that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general surgery, cardiothoracic, and head and neck surgical procedures. The company also manufactures EndoWrist instruments consisting of forceps, scissors, electrocautery, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures. In addition, it offers da Vinci single-site instruments and accessories that allow da Vinci Si surgical systems to work through a single incision; and EndoWrist One vessel sealer, a wristed single-use instrument intended for bipolar coagulation and mechanical transection of vessels up to 7 mm in anastomoses in general, gynecologic, and urologic surgery; and sells various accessory productsdiameter and tissue bundles that fit in the jaws of the instrument. Further, the company provides EndoWrist Stapler 45 instrument, a wristed stapling instrument intended for resection, transaction, and/or creation of, such as sterile drapes, 3-D stereo endoscopes, camera heads, light guides, and other items that are used in conjunction with the da Vinci surgical system. Intuitive Surgical, Inc. markets its products directly and through distributors in the United States and internationally. The company was founded in 1995 and is headquartered in Sunnyvale, California.

2,792 Employees
Last Reported Date: 02/3/14
Founded in 1995

intuitive surgical inc (ISRG) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $560.0K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $391.4K
Senior Vice President of Scientific Affairs
Total Annual Compensation: $380.0K
Chief Compliance Officer, Senior Vice Preside...
Total Annual Compensation: $365.7K
Principal Accounting Officer, Vice President ...
Total Annual Compensation: $227.6K
Compensation as of Fiscal Year 2013.

intuitive surgical inc (ISRG) Key Developments

Intuitive Surgical, Inc. Provides Preliminary Unaudited Earnings Guidance for the First Quarter of 2014

Intuitive Surgical, Inc. provided preliminary unaudited earnings guidance for the first quarter of 2014. For the quarter, the company anticipates revenue to be approximately $465 million, down 24% compared with $611 million for the first quarter of 2013. Revenue reflects a $26 million deferral associated with a customer trade-out program for the newly launched da Vinci Xi Surgical System. Excluding the impact of the trade-out program, revenue would have been $491 million, a decrease of 20% compared with the prior year. The company also announced a pre-tax charge of $67 million to reflect estimated costs of settling a number of product liability legal claims against the company. The claims are related to alleged complications from surgeries performed with certain versions of Monopolar Curved Scissors instruments that were the subject of a recall in 2013 and with a first-generation MCS tip cover that was the subject of a market withdrawal in 2012. The deferrals reduced first quarter 2014 system revenue by approximately $24 million as well as instrument and accessory revenue by $2 million. The Company expects to recognize all $26 million of the revenue deferrals within 2014.

Da Vinci Presents at 10th Annual CIS Private Equity and Venture Capital, Apr-09-2014 11:00 AM

Da Vinci Presents at 10th Annual CIS Private Equity and Venture Capital, Apr-09-2014 11:00 AM. Venue: Marriott Moscow Royal Aurora, Moscow, Russia. Speakers: Oleg Jelezko, Managing Partner.

Intuitive Surgical Announces New da Vinci Xi Surgical System

Intuitive Surgical, Inc. announced the FDA clearance and U.S. introduction of the da Vinci Xi Surgical System, a technological leap forward in replacing large-incision abdominal surgeries (open surgery) with a minimally invasive approach. The da Vinci Xi System has broader capabilities than prior generations of the da Vinci System. It can be used across a wide spectrum of minimally invasive surgical procedures and has been optimized for complex, multi-quadrant surgeries. For more than a decade, da Vinci Surgical Systems have provided patients with a minimally invasive alternative to open surgery that reduces many of the costs and complications associated with open procedures. Intuitive Surgical designed the new da Vinci Xi System with the goal of further advancing the technology used in minimally invasive surgery for complex diseases and conditions in gynecology, urology, thoracic, cardiac, and general surgery. With the U.S. introduction now underway, Intuitive Surgical will be seeking regulatory clearances to market the da Vinci Xi System around the world. Efficient Anatomical Access, Crystal Clear 3D-HD Visualization: By enabling efficient access throughout the abdomen and chest, the da Vinci Xi System expands upon core da Vinci System features, including wristed instruments, 3D-HD visualization, intuitive motion, and an ergonomic design. As with all da Vinci Surgical Systems, the da Vinci Xi System's immersive 3D-HD vision system provides surgeons a highly magnified view, virtually extending their eyes and hands into the patient. Compared to prior da Vinci Systems, the da Vinci Xi System's key features include: A new overhead instrument arm architecture designed to facilitate anatomical access from virtually any position. A new endoscope digital architecture that creates a simpler, more compact design with improved visual definition and clarity. An ability to attach the endoscope to any arm, providing flexibility for visualizing the surgical site. Smaller, thinner arms with newly designed joints that offer a greater range of motion than ever before. Longer instrument shafts designed to give surgeons greater operative reach. In addition, the da Vinci Xi System is built to be compatible with Intuitive Surgical's Firefly(TM) Fluorescence Imaging System. While it is not currently available, the company plan to seek regulatory clearance for use of Firefly Imaging with the da Vinci Xi System. This technology is currently available as an option with the da Vinci Si(TM) model, and it is used to provide the surgeon with additional visual information in a variety of surgical procedures by enabling real-time visualization and assessment of vessels, bile ducts and tissue perfusion. A System Designed For the Future: The da Vinci Xi System is an expandable technology platform that is designed to accommodate and seamlessly integrate a range of current technologies in areas such as imaging, advanced instruments and anatomical access, as well as future innovations. To provide hospitals with choices to match their needs, Intuitive Surgical will continue to offer the current da Vinci Si System, which addresses a broad span of procedure complexity, and the da Vinci Si-e(TM) System, a lower-cost system suited for less complex surgeries.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISRG:US $411.99 USD -3.14

ISRG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cerner Corp $54.00 USD +0.02
CR Bard Inc $139.49 USD +0.23
Edwards Lifesciences Corp $81.29 USD +0.86
Endo International PLC $57.26 USD -0.44
Zimmer Holdings Inc $90.99 USD -0.58
View Industry Companies
 

Industry Analysis

ISRG

Industry Average

Valuation ISRG Industry Range
Price/Earnings 24.8x
Price/Sales 7.0x
Price/Book 4.5x
Price/Cash Flow 23.7x
TEV/Sales 6.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTUITIVE SURGICAL INC, please visit www.intuitivesurgical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.